Evoke Pharma Inc Quarterly Interest Expense in USD from Q1 2014 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Evoke Pharma Inc quarterly/annual Interest Expense history and growth rate from Q1 2014 to Q4 2024.
  • Evoke Pharma Inc Interest Expense for the quarter ending December 31, 2024 was $126K, a 0% increase year-over-year.
  • Evoke Pharma Inc Interest Expense for the twelve months ending December 31, 2024 was $501K, a 0.27% increase year-over-year.
  • Evoke Pharma Inc annual Interest Expense for 2024 was $501K, a 0.27% increase from 2023.
  • Evoke Pharma Inc annual Interest Expense for 2023 was $500K, unchanged from 2022.
  • Evoke Pharma Inc annual Interest Expense for 2022 was $500K, a 0.01% decline from 2021.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $501K $126K +$2.00 +0% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-13
Q3 2024 $501K $126K -$1 0% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $501K $125K -$1 0% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $501K $125K +$1.37K +1.11% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $500K $126K -$1 0% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-13
Q3 2023 $500K $126K +$1.00 +0% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $500K $125K $0 0% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $500K $123K $0 0% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $500K $126K +$1.00 +0% Oct 1, 2022 Dec 31, 2022 10-K/A 2024-05-14
Q3 2022 $500K $126K $0 0% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $500K $125K $0 0% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $500K $123K -$51 -0.04% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $500K $126K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-21
Q3 2021 $126K +$75.5K +149% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $125K +$122K +4178% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 $123K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q3 2020 $50.5K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $2.91K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q3 2015 $240K $78.4K +$72.5K +1228% Jul 1, 2015 Sep 30, 2015 10-Q 2015-11-12
Q2 2015 $167K $77.7K +$19.3K +33.1% Apr 1, 2015 Jun 30, 2015 10-Q 2015-08-13
Q1 2015 $148K $77K +$40.1K +109% Jan 1, 2015 Mar 31, 2015 10-Q 2015-05-14
Q4 2014 $108K $6.59K Oct 1, 2014 Dec 31, 2014 10-K 2015-03-04
Q3 2014 $5.91K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 $58.4K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 $36.9K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.